Last reviewed · How we verify
ICG-guided bowel perfusion assessment — Competitive Intelligence Brief
phase 3
Surgical imaging agent
Surgery / Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
ICG-guided bowel perfusion assessment (ICG-guided bowel perfusion assessment) — Leiden University Medical Center. ICG (indocyanine green) fluorescence imaging enables real-time visualization of bowel perfusion during surgery to assess tissue viability and prevent anastomotic complications.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ICG-guided bowel perfusion assessment TARGET | ICG-guided bowel perfusion assessment | Leiden University Medical Center | phase 3 | Surgical imaging agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Surgical imaging agent class)
- Leiden University Medical Center · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ICG-guided bowel perfusion assessment CI watch — RSS
- ICG-guided bowel perfusion assessment CI watch — Atom
- ICG-guided bowel perfusion assessment CI watch — JSON
- ICG-guided bowel perfusion assessment alone — RSS
- Whole Surgical imaging agent class — RSS
Cite this brief
Drug Landscape (2026). ICG-guided bowel perfusion assessment — Competitive Intelligence Brief. https://druglandscape.com/ci/icg-guided-bowel-perfusion-assessment. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab